STANDARD BIOTOOLS INC - NOTE 2.750% 2/0

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Debt / NOTE 2.750% 2/0
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of STANDARD BIOTOOLS INC - NOTE 2.750% 2/0

Period Principal Value Change Price Investors
2025 Q3 $0 $0 -$7.96K 0
2025 Q2 $42K $49.5K -$31.6K $497.74 2
2025 Q1 $74K $81K -$791K $0.99 6
2024 Q4 $82K $864K +$791K $0.99 7
2024 Q3 $74K $81.1K -$37.6K $0.99 6
2024 Q2 $112K $119K +$20.8K $0.99 8
2024 Q1 $91K $98K -$6.14K $0.99 5
2023 Q4 $97K $104K +$38.00 $0.99 6
2023 Q3 $97K $102K +$27.9K $0.98 6
2023 Q2 $68K $73.2K -$723K $0.96 4
2023 Q1 $35K $796K +$698K $0.95 5
2022 Q4 $97K $657K -$2.82K $0.94 6
2022 Q3 $99K $100K $0.95 5
2022 Q2 $99K $102K $0.95 5
2022 Q1 $99K $102K $0.95 5
2021 Q4 $99K $104K $0.98 5
2021 Q3 $57K $64K $1.00 4
2021 Q2 $57K $64K +$6K $1.00 4
2021 Q1 $51K $57K -$112K $0.97 3
2020 Q4 $169K $171K +$8.46K $1.00 4
2020 Q3 $160K $169K +$4.07K $1.00 5
2020 Q2 $156K $157K -$28.1K $1.00 6
2020 Q1 $184K $183K +$14.8K $0.95 6
2019 Q4 $187K $185K -$48.2M $0.96 7
2019 Q3 $49.9M $48.4M +$926K $0.97 9
2019 Q2 $49M $47M +$101K $0.96 12
2019 Q1 $48.9M $46.1M +$130K $0.94 11
2018 Q4 $48.7M $44.9M +$687K $0.92 13
2018 Q3 $48.7M $42.5M +$179K $0.87 15
2018 Q2 $48.5M $39.2M +$1.99M $0.81 15
2018 Q1 $44.8M $38.8M -$127M $0.85 17
2017 Q4 $196M $162M +$9.01M $0.83 22
2017 Q3 $176M $130M -$2.66M $0.74 22
2017 Q2 $184M $115M +$673K $0.62 27
2017 Q1 $182M $123M +$187K $0.68 27
2016 Q4 $181M $127M -$5.28M $0.70 31
2016 Q3 $180M $118M -$1.36B $0.61 34
2016 Q2 $187M $113M +$7.74M $0.60 32
2016 Q1 $185M $102M -$226K $0.55 33
2015 Q4 $186M $116M -$7.02M $0.62 35
2015 Q3 $195M $141M +$7.96M $0.73 31
2015 Q2 $196M $174M -$21M $0.88 29
2015 Q1 $198M $210M +$28.8M $1.06 30
2014 Q4 $165M $152M -$26M $0.90 36
2014 Q3 $187M $167M +$5.42M $0.89 36
2014 Q2 $177M $167M +$14.9M $0.95 33
2014 Q1 $163M $186M +$178M $1.14 23